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1. Introduction
In order to achieve sustainable development, environmental protection shall constitute an
integral part of the development process and cannot be considered in isolation from it [1].
The environment, especially water ecosystem, is continuously loaded with foreign organic
chemicals (xenobiotics) released by urban communities and industries. Water is not a com‐
mercial product like any other but, rather, a heritage which must be protected, defended
and treated as such [2]. In the 20th century, many organic compounds, such as polychlorinat‐
ed biphenyls (PCBs), organochlorine pesticides (OCPs), polycyclic aromatic hydrocarbons
(PAHs), polychlorinated dibenzo-p-dioxins (PCDDs) and dibenzofurans (PCDFs) have been
produced and, in part, released into the environment [3]. The ultimate sink for many of
these contaminants is the aquatic environment, either due to direct discharges or to hydro‐
logic and atmospheric processes [4]. In the 21st century „new“ pollutants namely pharma‐
ceuticals, cosmetics and endocrine disrupting chemicals (EDCs) have become a source of
concern. Collectively, they are referred to as PPCPs (Pharmaceuticals and Personal Care
Products) and are now viewed as emerging contaminants. A wide range of pharmaceutical
and personal care products (PPCPs) is available on the market. From this range various
classes, e.g., antibiotics, antiphlogistics, antiepileptics, beta-blockers, lipid regulators, vaso‐
dilators, and sympathomimetics, have been detected in drinking water, groundwater,
wastewater, sewage, and manure [5]. In last time there is increasing evidence that some of
these compounds are persistent in the environment, impacting nontarget organisms in vari‐
ous ways including changes in sex ratios of higher organisms [6,7]. The presence of a xeno‐
© 2013 Zlámalová Gargošová et al.; licensee InTech. This is an open access article distributed under the terms
of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits
unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
biotic compound in a segment of an aquatic ecosystem does not, by itself, indicate injurious
effects. Traditional chemical measurements alone are an insufficient basis for ecotoxicity as‐
sessments. In general, both basic and advanced analytical chemical instruments such as
ICP/MS, GC/MS, HPLC/MS etc. are used for water quality analysis. However, it is difficult
to distinguish accurately the diverse and complex chemicals, even when using those ad‐
vance chemical instruments. Furthermore, it is also almost impossible to detect the impact
on living organisms in the receiving environment due to their bioavailability and the inter‐
action caused by the synergistic and antagonistic effect of different chemicals. Therefore a
new approach of identifying viable and ecologically relevant invertebrate toxicity testing
models seems very promising to assess the biological effects and ecological risk of exotic
chemicals when released into the environment as a battery of single species bioassays [8].
1.1. Pharmaceuticals
Pharmaceuticals (also drugs, medicaments, medications, medicines etc.) are biologically ac‐
tive substances designated for use in the medical diagnosis, cure, treatment, or prevention of
disease [9]. These compounds improve the quality of human life, but due to their increasing
production and consumption resulting in their growing input into the environment there is
increasing impact of these compounds on the natural ecosystems, caused either by the active
compounds contained in medicaments or by their metabolites and transformation products
[10]. These compounds are sometimes called as pseudo-persistent pollutants, because in
many cases their persistence is not high, but due to continual input their levels in the envi‐
ronment are kept less or more constant. The discharges from waste water treatment plants
represent one important source of pharmaceuticals in the water ecosystem, because most of
drugs is incompletely removed in waste water treatment plants (WWTP) [11-13]; they could
be partially removed by sorption on the sewage sludge or degraded by microorganisms in
activated sludge. The removal efficiency depends on many factors like drug properties, type
and parameters of the cleaning process, age of the activated sludge. The sludge activity
could be also negatively influenced by the presence of antibiotics in treated waste water.
Another important source of pharmaceuticals in the water ecosystem is agriculture, espe‐
cially livestock production, where growth stimulants are used to increase production and
antibiotics are administered as prophylactic medication to animals. Biotransformation of
drugs during animal digestion is not very effective; from 30 to 90 % of administered active
compounds is excreted unchanged [10,14] and enter the environment directly via urine or
faeces, or in manure and suds used as fertilizers.
Non-steroidal anti-inflammatory drugs (NSAIDs) with analgesic, antipyretic and anti-inflam‐
matory effects are one group of the most frequently used medicaments. Ibuprofen and para‐
cetamol followed by diclofenac, ketoprofen and naproxen are the most well-known
members of this group. Their extensive use is caused by the fact, that many drugs in this
group do not require medical prescription. These compounds also belong to the most fre‐
quently detected pharmaceuticals in the European waters. E.g, for ibuprofen the concentra‐
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tions of units to tens of ng.L-1 in surface water, tens of ng.L-1 in raw waste water and from
tenths to units of ng.L-1 in discharged water were found in the Czech Republic [15].
Antibiotics are another important group of pharmaceuticals. This term originally denoted
“any substance produced by a microorganism that is antagonistic to the growth of other mi‐
croorganisms in high dilution” [16]. Nowadays also synthetic compounds are included in
this group. Antibiotics have been recently classified as a priority risk compounds due to
their high toxicity to algae and bacteria. Hence, these compounds in surface water have the
potential to disrupt the key bacterial cycles and/or processes critical to aquatic ecology (nitri‐
fication/denitrification), agriculture (soil fertility) and animal production (rudimentary proc‐
esses) [17,18]. Under long-term exposition the resistance of some pathogenic organisms
could develop [11,12].
Macrolide antibiotics are a group of drugs frequently used in human and veterinary medicine.
These primarily bacteriostatic antibiotics with a broad antibacterial spectrum are probably
the largest group of natural medicines. Macrolides have acquired its name by macrocyclic
lactone ring with 14, 15 or 16 carbon atoms, substituted with alkyl, aldehyde, ketone or hy‐
droxyl groups, and with one or more neutral or basic amino sugars bonded to the ring by
glycosidic bond. The first macrolide antibiotic, erythromycin, was isolated in 1952 from the
metabolic product of fungus Streptomyces erythreus [19].
Macrolide antibiotics can be classified into four groups [20]:
1. Natural macrolides of 1st generation have a short half-life; therefore they must be ad‐
ministered in relatively high and frequent doses. There is a potential of interactions
with some other drugs.
2. Synthetic macrolides of 2nd generation have more favourable pharmacokinetic proper‐
ties, applications are therefore less frequent and doses are lower than at first -generation
macrolides. There is also a lower incidence of drug interactions.
3. Azalides are formed by incorporating nitrogen into the 14-member lactone ring. From
other macrolides they differ with high half-life and very slow release from tissues.
4. Ketolides are the newest and so far little studied group of macrolide antibiotics. These
drugs were prepared by replacing sugar cladinose in the 14-member lactone ring by ke‐
to-group and by attaching a cyclic carbamate group in the lactone ring. Due to these
modifications ketolides have much broader antimicrobial spectrum than other macro‐
lides; besides, they are also effective against macrolide-resistant bacteria, due to their
ability to bind at two sites at the bacterial ribosome.
1.2. Musk Compounds
Musk compounds -  synthetic  fragrances – are substances with pleasant smell  which are
present in personal hygiene products (perfumes, cosmetics, soaps, and shampoo), in clean‐
ing and disinfection products, industrial cleaning products, air fresheners, etc. to give them
characteristic and pleasant scent. These compounds have been marketed since the begin‐
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ning of 20th century and their industrial production has significantly increased during the
last  50  years  [21].  Nowadays,  four  major  classes  of  synthetic  fragrances  could  be  met:
nitromusks,  polycyclic  musks,  macrocyclic  musks and alicyclic  (or  linear)  musks.  Nitro‐
musks were the first produced compounds of this type; structure of these compounds is
based on two-  or  threefold nitrated benzene with additional  substitution by alkyl-,  me‐
thoxy- or keto- groups. Musk xylene (MX), musk ketone (MK) and musk ambrette (MA)
are the most important members of this group. These compounds show musk-like odour
in spite  of  the fact  that  their  structure is  very different  from natural  musk compounds.
They are partially soluble in water (0.15 ng.L-1  for MX; 0.46 ng.L-1  for MK), but their rel‐
atively high octanol-water partition coefficients (log Kow = 4.4,  3.8 and 4.0 for MX, MK
and MA, respectively) [22] indicate high bioaccumulation potential in water biota. These
compounds are also relatively persistent. According to data published till now, nitro musks
show low or none acute toxicity to aquatic organisms, but they are potentially toxic over
long  time  period  [23,24].  It  has  been  suggested  that  their  transformation  products  are
potentially  highly toxic  [25].  The worldwide production of  MX and MK (which are  the
only two nitromusks of  industrial  importance today) in 2000 was estimated to 200 met‐
ric tons and it shows decreasing tendency [26].
Polycyclic musks with several cycles in their structure were discovered in 1950s [27]. Chemi‐
cally they are indane, tetraline or coumarine derivatives and tricyclic compounds. Current‐
ly, these musks are the most widely used. Galaxolide (HHCB) and tonalide (AHTN) in
recent years are the most important commercial synthetic musks [21,28] followed by celesto‐
lide (ADBI), phantolide (AHMI), and traesolide (ATII). Total worldwide use of polycyclic
musks in year 2000 was approximately 4000 tons [26]. These compounds are more resistant
against light and bases and bind well to fabric. Nevertheless, HHCB and AHTN are toxic to
aquatic invertebrates at concentration levels of ppb to low ppm, but they are almost non-
toxic to fish; similar situation occurs during longer exposition [29]. The first report about the
presence of these compounds in water and fish appeared in 1984, one year later these com‐
pounds were found in human samples [27].
Macrocyclic musk compounds were discovered in 1926 by Austrian chemist Leopold Ru‐
zicka [30,31] who characterized natural musks muscone and civetone as cyclic macromole‐
cules and proposed the method of their synthesis. Since then, many other compounds of
this  type has been characterized and synthesized.  It  was found that natural  macrocyclic
musks are 15- or 17-membered rings, musks of animal origin are mainly ketones, whilst
those of plant origin are lactones. These compounds show excellent stability to light and
alkaline condition and very good fixation to fabric, nevertheless their synthesis is difficult
and usually multi-step procedure, and therefore their production costs are high. Due to this
fact the use of these compounds is limited, but they are expected to be of increasing impor‐
tance in future [27].
Alicyclic musks, known also as linear musks or cycloakyl esters, represent the youngest
group of synthetic musks. Their structure is formed by modified cykloalkyl esters. The first
compound of this group – cyclomusk - was introduced in 1975 [32]. In 1990, the first com‐
mercially successful linear musk – helvetolide – was launched, another linear musk – Ro‐
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mandolide – was described ten years later [33]. Due to relative novelty there is lack of
information describing their occurrence in the environment and their ecotoxicity. A wide
range of musk compounds of this group are produced and marketed by the Czech company
Aroma Prague Ltd.
2. Environmental Analysis
2.1. Target Compounds
For this study six frequently used acidic non-steroid anti-inflammatory drugs (NSAIDs)
were selected. Figure 1 shows their structures and Table 1 summarizes their physical-chemi‐
cal properties.
Figure 1. Structures of selected NSAIDs.
Compound CAS No. Molecular mass(g.mol-1) pKa log KOW
Salicylic acid 69-72-2 138.1207 2.97 2.4
Ibuprofen 15687-27-1 206.2808 4.91 3.6
Paracetamol 103-90-2 151.1626 9.38 0.4
Naproxen 22204-53-1 230.2592 4.15 2.8
Ketoprofen 22071-15-4 254.2806 4.45 3.2
Diclofenac 15307-86-5 296.149 4.15 3.9
Table 1. Physical-chemical properties of selected NSAIDs [34-37].
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From the group of macrolide antibiotics following drugs were selected:
Erythromycin is a mixture of macrolide antibiotics that are produced by the microorganism
Streptomyces erythreus. The main ingredient is erythromycin A. Erythromycin is a white to
pale yellow powder or form a colourless to pale yellow crystals. It is slightly hygroscopic,
poorly soluble in water, soluble in ethanol and methanol. It is metabolized in the acidic en‐
vironment of the stomach to inactive by-products (ketones, alcohols, ethers), which are re‐
sponsible for its low bioavailability and gastrointestinal side effects. This bacteriostatic
macrolide antibiotic is used for treatment of respiratory infections caused mainly mycoplas‐
ma, chlamydia, staphylococci or streptococci, as well as of infections of the skin or urinary
tract.
Clarithromycin is used for treating of respiratory infections caused mainly by mycoplasma,
chlamydia, staphylococci or streptococci, as well as of infections of the skin or urinary tract.
Clarithromycin has strong antibacterial properties and is more resistant against acidic envi‐
ronment than erythromycin; it has also improved pharmacokinetic properties and is better
tolerated in the GIT. Clarithromycin is a white crystalline powder, practically insoluble in
water but soluble in acetone.
Roxithromycin is a newer macrolide antibiotic with better tolerance than that of erythromy‐
cin. It is used to treat the same diseases as erythromycin and also to treat isosporiases.
Chemical structures of selected macrolide antibiotics are in Figure 2.
Figure 2. Structures of selected macrolide antibiotics.
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Compound CAS No. Molecular mass(g.mol-1) log KOW
Erythromycine 114-07-8 733.93 3.06
Clarithromycine 81103-11-9 747.95 3.16
Roxithromycine 80214-83-1 837.05 2.75
Table 2. Physical-chemical properties of selected macrolides [34,35,37].
Musk compounds selected for this study are from the group of linear musks produced and
marketed in the Czech Republic by Aroma Prague Company. They are used for preparation
of various fragrances and perfume compositions. Their structures are given in Figure 3 and
physical-chemical properties in Table 3.
Figure 3. Structures of selected linear musks.
Compound CAS No. Molecular mass(g.mol-1) log KOW
Arocet 88-41-5 198.30 4.42
Aroflorone 16587-71-6 168.26 3.40
Lilial 80-54-6 204.31 4.36
Linalool 126-91-0 154.25 3.38
Isoamyl salicylate 87-20-7 208.25 4.49
Table 3. Physical-chemical properties of selected linear musks.
2.2. Sampling locality
The presence of target compounds was monitored in the wastewater from municipal waste
water treatment plant (WWTP) Brno – Modřice (catchment region for population of about
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500,000 people). This facility was launched in 1961 as classic two-stage plant with anaerobic
sludge stabilization. In the period between 2001 – 2003 the overall reconstruction and exten‐
sion of the WWTP was realized with the main objective to meet the treated wastewater ef‐
fluent limits set by Czech and European standards and regulations, and to ensure sufficient
capacity of the facility to accommodate the growing demand of the city of Brno with almost
500 thousand of inhabitants and several industrial facilities, and also increasing number of
the surrounding agglomerations successively connecting to the Brno sewerage system.
Nowadays, the technology in WWTP Brno-Modřice corresponds to the EU parameters.
Waste water cleaning process includes mechanical removal of rough solid particles – me‐
chanical treatment, which is followed by fat removal. Water is then directed to the sedimen‐
tation tanks for removal of fine particles. The next step is biological treatment under
anaerobic conditions where dephosphatation and denitrification occurs, followed by biolog‐
ical degradation under aerobic conditions. The rest of the non-biodegradable phosphorus is
subsequently removed by chemical precipitation with ferric sulphate. Activated sludge is re‐
moved from the water in sedimentation tank, water is then discharged into the recipient and
sludge is thickened and decayed. Produced bio-gas is used for the combined generation of
heat and electricity. The residence time (technological delay) between inlet and comparable
outlet in Brno WWTP is 24 hours.
Figure 4. Sampling locality – waste water treatment plant Brno - Modřice.
Composite 24-hour samples were collected at inflow and outflow of the WWTP by automat‐
ic sampling device in 2-hours intervals. Individual portions were collected in the dark glass
sample containers with a capacity of 1 L. Samples for analysis of NSAIDs were collected at
inflow and outflow of WWTP during July and August 2011, for determination of macrolides
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and musk compounds from 11th to 20th of April 2011. Samples were picked up from the
WWTP daily and transported to laboratory, where they were either analysed immediately
or stored in a refrigerator at 5 °C and analysis was initiated within 24 hours.
2.3. Analysis of Pharmaceuticals
Solid phase extraction (SPE) was applied for the isolation of target compounds from waste
water. The suspended particles were removed by filtration using Büchner funnel and fil‐
ter  paper  Munktell  Filtrak No 388 and No 390 for  inflow samples  and 390 for  outflow
samples and pH of the samples was adjusted to a value of 2 by addition of hydrochlor‐
ic acid (NSAIDs) or formic acid (antibiotics).  300 mL of waste water was then subjected
to  solid  phase  extraction  using  Oasis  HLB cartridges  (volume 3  mL,  60  mg of  sorbent,
Waters, USA), which were previously activated by 6 mL of methanol and washed with 6
mL Milli-Q water at pH = 2. After loading of sample the cartridge was again washed by
6 mL Milli-Q water at pH = 2, dried for 5 minutes under flow of nitrogen and then the
target compounds were eluted by 6 mL (NSAIDs) or 10 ml (antibiotics) of methanol. The
eluate was then evaporated to dryness under gentle stream of nitrogen. For the analysis
of NSAIDs the residue was dissolved in 300 μL of BGE and analysed by capillary zone
electrophoresis with UV detection.  For analysis  of  macrolides the residue was dissolved
in 1 ml of acetonitrile and analysed by HPLC/MS.
2.3.1. Analysis of NSAIDs by capillary zone electrophoresis:
Agilent CE instrument equipped with UV-VIS detector of DAD type was used. Analytical
conditions were as follows.
• Separation capillary: fused silica uncoated, ID = 75 μm, L = 83.5 cm, l = 75.4 cm
• Background electrolyte (BGE): 25 mmol.L-1 Na2B4O7 in Milli-Q water (before each injec‐
tion, the capillary was treated successively with alkaline solution of 0.1 M NaOH, water
and BGE
• Separation voltage: 30 kV, positive polarity
• Temperature of separation capillary: 25 °C
• Detection: 210 nm (bandwith of 40 nm), 200 nm (bandwith of 20 nm), 230 nm (bandwith
of 10 nm)
• Sample injection: hydrodynamic, pressure pulse at capillary inlet 5 kPa for 5 s
• Analysis time: 25 min
Fig. 5 shows an example of electrophoregram.
Obtained results  together  with  removal  efficiency  and limits  of  detection  are  presented
in Table 4.
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Compound
Concentration Removal
efficiency
(%)
LOD
[µg.L-1]influent
[µg.L-1]
effluent
[µg.L-1]
Salicylic acid 5.58–44.15 0.47–3.53 97 0.46
Ibuprofen 10.94–42.32 1.18–2.75 96 1.17
Paracetamol 1.00–14.61 0.52–1.65 97 0.46
Naproxen 0.61–14.48 0.51–2.35 78 0.50
Ketoprofen 2.15–28.21 1.34–6.46 92 1.28
Diclofenac 1.09–9.46 1.02–2.17 92 0.98
Table 4. Concentrations of NSAIDs at inflow and outflow, removal efficiency and limits of detection.
The ranges of concentrations of selected drugs in the influent and effluent and average re‐
moval efficiency of the WWTP for each drug are listed in Table 4. All selected drugs were
detected in analysed samples of wastewater. Salicylic acid (average concentration 28.21
μg.L-1) and ibuprofen (average concentration 23.11 μg.L-1), were detected at highest concen‐
trations and almost in all samples. It is caused by the fact, that these compounds are con‐
tained in the majority of the most frequently used drugs in the Czech Republic. The levels of
other monitored analgesics were below 10 μg.L-1. Relatively low concentration of favourite
painkiller – paracetamol – was surprising, but the reason could be partial decomposition of
this compound in waste water before the inflow to the WWTP. Ketoprofen, diclofenac and
naproxen were detected in wastewater only in some cases.
Figure 5. Electrophoregram of NSAIDs standards: EOF – Mesityl oxid (marker of electroosmotic flow); PAR – paraceta‐
mol; KET – ketoprofen; DIC – diclofenac; IBU – ibuprofen; NAP – naproxen; SAL - salicylic acid.
Average removal efficiency of all analysed compounds was above 90 %, except for naproxen
with an average removal efficiency of 78 %.
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2.3.2. Analysis of antibiotics by HPLC/MS
Analysis of samples was performed using high performance liquid chromatography with
mass spectrometric detection (HPLC/MS). Agilent 1100 Series liquid chromatograph with
Agilent 6320 spherical ion trap mass spectrometer and electrospray ionization were em‐
ployed. Zorbax Eclipse XDB - C18 column (2.1 x 150 mm, particles 3.5 μm) protected by Zor‐
bax Eclipse XDB - C18 precolumn (2.1 x 20 mm, particles 3.5 μm) was used for separation,
binary mobile phase consists from 10mM ammonium acetate (A) and acetonitrile (B), gradi‐
ent started from 25 % B to 55 % B in 3 min, then 90 % B in 10 min. Flow rate was 150
μL.min-1. Conditions for electrospray: pressure of nebulizing gas (N2) 20 psi, flow and tem‐
perature of drying gas (N2) 10 L.min-1 and 350 °C, respectively. Positive ions were scanned
within the range m/z 100 – 900. Individual compounds were identified by the combination
of retention time and quasi-molecular ion detection (erythromycin: tR =11.2 min, m/z = 734.8;
clarithromycin: tR = 13.0 min, m/z = 748.3; roxithromycin: tR = 13.4 min, m/z = 837.4), external
standard method based on the response on fragmentograms corresponding to the quasi-mo‐
lecular peaks of individual compounds was used. Metrological parameters of used analyti‐
cal method are presented in Table 5.
Parameter
Compound
Erythromycin Clarithromycin Roxithromycin
Coefficient of determination (R2) 0.9962 0.9993 0.9971
LOD [μg.L-1] 0.1440 0.2428 0.0970
LOQ [μg.L-1] 0.4305 0.7251 0.2903
Table 5. Metrological parameters of HPLC/MS method.
In real samples the presence of macrolide antibiotics was proved only exceptionally and at
levels close to limits of detection (erythromycin 17., 18. and 19. 4. 2011 at inflow at levels of
0.274 μg.L-1, roxithromycin 12.4.2011 at outflow 0.1 μg.L-1). Clarithromycin was not detected
at concentrations exceeding LOD at all. Therefore it could be concluded that macrolide anti‐
biotics don’t represent any serious risk for the receiving water.
2.4. Analysis of musk compounds
Solid Phase Microextraction (SPME) in head-space mode was used for the isolation of target
analytes from waste water. Fibre with 65 μm mixed layer polydimethylsiloxane – divinyl‐
benzene was selected as optimal on the base of previous studies realized in our laboratory.
22 mL glass vials closed with Teflon-lined silicon septum were used. 14 mL of raw sample
was placed into the vial, 3.75 g NaCl was added, after inserting of magnetic stirrer vial was
closed and heated up to the temperature of 80 °C in water bath. Magnetic stirrer was set to
900 rpm. Equilibration time was 5 minutes, followed by 40 minute sorption. Blank samples
were treated by the same method using de-ionized water.
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Compound Quantification ion(m/z) Qualifier ions (m/z) tR (min)
Linalool 93 71 121 9.12
Arocet (2 isomers) 82 123 57 13.483 14.044
Aroflorone 98 168 71 15.330
Lilial 189 204 147 20.675
Isoamyl salicylate 120 138 208 20.825
Table 6. Experimental parameters for the GC/MS analysis of linear musks.
Isolated compounds were analysed by GC/MS using Agilent 6890N GC and Agilent 5973 MS
equipped with quadrupole analyser and electron ionization @ 70 eV. Separation column was
DB-5MS (20 m x 0.18 mm x 0.18 μm) (J&W), helium 6.0 (SIAD, Czech Republic) at a flow rate
of 0.8 mL.min-1 (constant flow mode) was the carrier gas. Desorption from SPME fibre was
realized in split/splitless injector of the GC in splitless mode for 3 min at a temperature of
250 °C. Column temperature program was as follows: 50 °C for 3 min, then 10°/min to 90 °C,
then 5°/min to 120 °C, hold 4 min, then 10°/min to 160 °C, 5°/min to 185 °C, 20°/min to 285
°C, final isotherm 2 min. GC/MS interface temperature was set to 285 °C, temperature of ion
source was 250 °C. Mass spectrometer was operated in SIM mode; parameters are summar‐
ized in Table 6.
Date
Linalool
[μg.L-1]
Arocet
[μg.L-1]
Aroflorone
[μg.L-1]
Lilial
[μg.L-1]
Isoamyl
salicylate
[μg.L-1]
Inf
low
Ou
tflo
w
Inf
low
Ou
tflo
w
Inf
low
Ou
tflo
w
Inf
low
Ou
tflo
w
Inf
low
Ou
tflo
w
11.4.11 61.31 ND 2.633 ND 3.442 ND 1.222 0.049 0.975 NQ
12.4.11 42.33 NQ 2.406 ND 1.342 ND 0.406 0.049 0.922 ND
13.4.11 33.28 NQ 2.847 ND 1.413 ND 0.439 0.017 0.328 ND
14.4.11 36.75 ND 1.388 ND 0.809 NQ 0.429 0.060 0.589 NQ
15.4.11 25.92 0.199 0.473 ND 0.369 ND 0.197 0.042 0.121 NQ
16.4.11 66.72 0.139 1.399 ND 1.427 ND 0.404 0.049 0.403 NQ
17.4.11 39.57 NQ 0.546 ND 0.727 ND 0.307 0.033 0.202 ND
18.4.11 90.81 0.114 3.223 ND 5.336 ND 0.391 0.058 0.492 NQ
19.4.11 75.67 ND 4.294 ND 2.419 NQ 0.684 0.065 0.734 NQ
20.4.11 84.79 ND 4.406 ND 0.925 ND 0.433 0.047 0.495 ND
Average 55.72 0.046 2.361 0.0002 1.821 0.0007 0.491 0.047 0.526 0.0003
LOD 0.0012 0.0004 0.0011 0.0002 0.0004
LOQ 0.0041 0.0014 0.0037 0.0008 0.0012
Table 7. Concentrations of selected linear musks in waste water. For the calculation of average compound
concentrations following values were used: ND = 0.5 ∙ LOD and NQ = LOD.
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Table 7 presents the concentrations of selected linear musks in raw and cleaned waste water.
Linalool was found in highest concentrations at inflow ranging from 33 to 91 μg.L-1, fol‐
lowed by arocet and aroflorone with levels in low units of μg.L-1. Inflow concentrations of
lilial and isoamyl acetate were in tenths of μg.L-1. These concentrations are lower than that
of polycyclic musks at the same locality – levels found for galaxolide and tonalide were in
hundreds and tens of μg.L-1, respectively [38]. For all linear musks except of lilial, high re‐
moval efficiencies were attained, usually more than 99.5 %. Lilial removal efficiency was be‐
tween 78.68 and 96.13 % (average 88.7 %). These results are very satisfactory.
3. Ecotoxicology
Our generation has recently stepped over a threshold of the new millennium. The growth of
the human population coupled with increasing consumption and overuse of natural resour‐
ces brings with it also growing impact on the total environment. The human activities that
have accelerated since the 18th century with the beginning of the industrial revolution led in
many cases to long-term consequences which disturbed the natural balance and gathered an
irreversible and uncontrollable character [39]. Effects of above mentioned human activities,
mainly uncontrolled release of various manmade chemicals, is not without adverse conse‐
quences. These negative effects are studied within the discipline of ecotoxicology, which
was firstly defined around 1969 by Dr. René Truhaut, a member of the French Academy of
Sciences. This new field of science “Ecotoxicology” he defined as “the study of adverse ef‐
fects of chemicals with the aim of protecting natural species and populations.” Thus ecotoxi‐
cology deals with potentially harmful effects of countless man-made chemicals and wastes
released into biosphere on organisms. Ecotoxicity involves the identification of chemical
hazards to the environment. "Ecotoxicity studies measure the effects of chemicals on fish,
wildlife, plants, and other wild organisms" [40,41]. Bioassays are one of the main tools in
ecotoxicological assessments. Ecotoxicology has the task to examine effects of chemicals or
environmental samples on species, biocenoses and ecosystems. Results of ecotoxicological
research constitute the main scientific background for setting immission standards for the
protection of the environment. The Water Policy Directive [2] of the European Union (EU)
strives for a good ecological and chemical status for surface waters. This Directive is to con‐
tribute to the progressive reduction of emissions of hazardous substances to water. Howev‐
er, the Directive is aimed especially at a monitoring of the state of the waters and is based on
a combined approach using control of pollution at source (substance-specific assessment)
through the setting of emission limit values and of environmental quality standards instead
of an assessing threats to the waters from effluent discharges [2,42]. The solution is the
whole effluent assessment (WEA), which can be defined as the assessment of the whole ef‐
fluents by using a range of biological methods or techniques in order to reveal (potential)
effects. It focuses on toxicity (acute and chronic), genotoxicity (including mutagenicity), bio‐
accumulation and persistence. Therefore WEA increases the understanding of the combined
effect of all known and unknown substances, especially in complex mixtures [43]. Global
evaluation of wastewaters should include ecotoxicological tests to complete the chemical
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characterization. The integrated assessment of biological effects of wastewater discharges in
the ecosystems is relevant and ecotoxicity tests are referred as extremely useful tools for the
identification of environmental impacts [44]. On the other hand there exist some ways how
to partially prevent environment and water ecosystem. On 1st June 2007 EU regulation
REACH entered into force. The law is the European Community Regulation on chemicals
and their safe use [45]. It deals with the Registration, Evaluation, Authorisation and Restric‐
tion of Chemical substances. The aim of REACH is to improve the protection of human
health and the environment through the better and earlier identification of the intrinsic
properties of chemical substances. Three specific properties of a chemical are used to de‐
scribe its potential hazard to the aquatic environment [46,47]:
• Aquatic toxicity: The hazard of a substance to living organisms, based on toxicity tests to
aquatic animals and plants.
• Degradability: The persistence of the substance in the environment, based on molecular
structure or analytical testing.
• Bioaccumulation/bioconcentration: The accumulation of a substance in living organisms
(from water sources for bioconcentration), which may or may not lead to a toxic effect;
based on calculations or bioconcentration factor (BCF) studies using fish.
Aquatic toxicity is determined using internationally harmonized test methods, which are
preferred; in practice, data from national methods may also be used where they are consid‐
ered as equivalent. Data are preferably to be derived using OECD Test Guidelines, US Envi‐
ronmental Protection Agency (EPA) or equivalent according to the principles of Good
Laboratory Practices (GLP). For ecotoxicity evaluation of chemicals fish, crustacean, algae
and freshwater plant (Lemna minor) are used. On the base of obtained results from tests the
hazards to the aquatic environment which they present is identified and chemical substan‐
ces are classified into categories and they are assigned risk phrases [46,48,49].
3.1. Ecotoxicity testing of chemical compounds
To assess the effect of chemical compounds on various aquatic organisms the ecotoxicity
tests, biotests, bioassays using organisms from various trophic levels are used. The goal of
the ecotoxicological tests is the determination of effective concentration (EC), eventually le‐
thal concentration (LC) or inhibition concentrations (IC) [40]. These parameters refer to the
concentration of toxic substance that results in 50% reduction of end-point relative to control
at a given period of time [50]. These concentrations of tested compounds cause the mortality
of 50 % testing organisms or 50% inhibition growth rate in relation to control group. Lower
values of LC (EC, IC)50 means higher toxicity of the tested chemical compounds. In accord‐
ance with testing regulation the limit test, preliminary tests and definitive test were conduct‐
ed with single compounds. In limit test concentration 100 mg.L-1 of tested compound is
used. Preliminary tests (range finding test) are used to find approximate toxicity of the
chemical compounds if it is unknown. In this case the dilution series is following: 100
mg.L-1, 10 mg.L-1, 1 mg.L-1, 0.1 mg.L-1 and 0.01 mg.L-1. The results of preliminary tests are
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used to determine the range of dilution series of the final test. From obtained experimental
endpoints (mortality, immobility, growth inhibition etc.) in ecotoxicity tests the ecotoxico‐
logical values EC50, IC50, LC50 are calculated
3.1.1. Daphnia magna – acute toxicity test
Daphnia magna is a common component of freshwater zooplankton. It refers to the group of
Arthropoda, Branchiopoda, Daphnidae. Daphnia are small arthropods of 1–5 mm in size. They
live in various aquatic environments. Ontogenesis of individual is direct without larval
stages. During the year there is one or several biological cycles in which parthenogenetic
generations are alternated by bisexual generations which enclose the cycle. Species D. magna
is the largest species of Daphnia group. Thus it is vulnerable to fish predation that it is ex‐
cluded from fish-inhabiting lakes. It occurs mainly in ephemeral habitats like small ponds
and rockpools where vertebrate predators are rare. D. magna is most commonly used species
in aquatic toxicity testing because of many characters that make it easy and economical to
culture it in the laboratory. It is relatively small but bigger than other daphnids, thus manip‐
ulation with it is easy. It has short life cycle, high fecundity, and parthenogenetic reproduc‐
tion. On the other hand in a few comparative studies D. magna tended to be less sensitive to
toxic substances than other cladorerans, and this may be due in part to life-history and size
differences [51,52]. Daphnids are integral part of water biocenosis and food chain; this is the
reason why their using in ecotoxicity testing is important. There exist many national and in‐
ternational standard methods which use this organism for acute or chronic ecotoxicity as‐
sessment [53-59].
Alternative small scale method Daphtoxkit FTM (purchased from MicroBioTests Inc., Gent,
Belgium) for the determination of EC50 value was used for our purposes. The Standard Op‐
erational Procedure of the Daphtoxkit FTM is in accordance with the OECD and ISO test pro‐
tocols for the acute Daphnia magna toxicity tests [54,55]. Standard Freshwater was prepared
with the concentrated salt solutions included in the kit. This medium, which has the compo‐
sition recommended by the ISO for acute toxicity tests with D. magna, is used as a hatching
medium and as a dilution medium for the preparation of the toxicant dilution series. Be‐
cause of low water solubility of tested substances DMSO as solvent for preparation of 100
mg.L-1 stock solutions of tested compounds was used. Maximal concentration of DMSO
used for dilution series preparation in tests was 3 %. This concentration doesn’t exhibit any
negative influence on testing organisms in control group. Ephippia were hatched in Petri
dishes with Standard Freshwater (ISO) medium three days before test at temperature 20 - 22
°C under continuous illumination of 6 000 lux. Pre-feeding of neonate with suspension of
spirulina powder was done two hours before the test to prove them energetic reserve. Daph‐
nids (aged less than 24 hours) were exposed to dilution series of tested compounds in pre‐
liminary and final tests. Experiments were conducted at temperature 20 °C in darkness
incubator. After 24 and 48 h the endpoint - immobility was observed. The values of 24hEC50
and 48hEC50 were calculated by probit analysis. The test was considered valid if the num‐
ber of dead organisms in the control did not exceeded 10 %.
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3.1.2. Thamnocephalus platyurus - acute toxicity test
Ecotoxicological evaluation of selected musk substances was done also via freshwater crus‐
taceans Thamnocephalus platyurus. It refers to class Branchiopoda orders Anostraca, originat‐
ed from North America. For calculation value of 24LC50 alternative test Thamnotoxkit FTM
was used (purchased from MicroBioTests Inc., Gent, Belgium). The T. platyurus assay has
already been incorporated in some countries in regional or national regulations for toxici‐
ty testing but requests have also been formulated from various sides to propose this micro‐
biotest to “international” organisations for endorsement as a “standard toxicity test”, for
specific applications in a regulatory framework. On the base of proposal to the Internation‐
al Standardisation Organisation (ISO) for consideration the T. platyurus  microbiotest as a
new ISO standard ecotoxicological  test  committee  draft  ISO/CD 14380 was in  2010 pre‐
pared. This test is often used to toxicity assessing in freshwater, waste water and determi‐
nation of acute toxicity of chemicals [60-62]. Thamnotoxkit FTM is similar to Daphtoxkit FTM
-  it  also contains all  the materials  to  perform six  complete  acute (24-hour)  toxicity  tests
(range-finding or definitive) based on mortality of testing organisms. Larvae of the fairy
shrimp T. platyurus  hatched from cysts are used. The test procedure followed the Stand‐
ard Operational Procedure manual of the Thamnotoxkit FTM microbiotest. Standard freshwa‐
ter was prepared by diluting of the concentrated salt solutions included in the kit to obtain
1 L of medium, which served for hatching of the cysts and for preparation of the toxicant
dilution series. In case of organisms T. platyurus acetone as solvent for preparation of 100
mg.L-1 stock solution of tested compounds was used. Maximal concentration of acetone used
for dilution series preparation in tests was 3 %, which have no negative effect on testing
organisms in control group. Before testing the eggs of T. platyurus were hatched 24 hours
at a temperature of 25 °C under continuous illumination at 4 000 lux. The assays were carried
out in the multiwell test plates provided in the kits in the darkness at temperature of 25 °C.
Larvae were exposed to dilution series of tested compounds in preliminary and final tests.
Lethality (endpoint for effect calculation) was observed after 24 h. The values of 24hLC50
were calculated by probit analysis.  The test was considered valid if  the number of dead
organisms in the control did not exceed 10 %.
3.2. Ecotoxicity of linear musk compounds
In our study four selected synthetic linear musk compounds were evaluated via alternative
ecotoxicity tests on freshwater crustaceans T. platyurus and D. magma: Arocet (2-tert-butylcy‐
clohexylacetate, Aroflorone (4-tert-amylcyclohexanone), Lilial [3-(4-tert-butylphenyl)-2-
methylpropanal] and Linalool (3,7-dimethylocta-1,6-diene-3-ol). All substances were
obtained from their producer Aroma Praha Company Ltd. Information on the occurrence of
these substances in waste water and surface water as well as information concerning their
ecotoxicity is absent in scientific literature. Material safety data sheet (MSDS), if available,
gives only data concerning their toxicity. The Globally Harmonized System for Classifica‐
tion and Labelling of Chemicals (GHS) describes testing for hazards to the aquatic environ‐
ment in Part 4, Chapter 4.1 [47]. The purpose of obtaining aquatic toxicity data for chemicals
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is to classify them to their acute or chronic toxicity in the hazard classification in different
classes. Ecotoxicological values obtained on the most sensitive of testing organisms (fish,
crustacean algae or other aquatic plant) in acute toxicity tests serve to classification in three
acute classification categories; ecotoxicological value < 1 mg.L-1, (class I-very toxic to aquatic
organisms); 1 - 10 mg.L-1 (class II-toxic to aquatic organisms); 10 - 100 mg.L-1 (class III-harm‐
ful to aquatic organisms). Substances with value EC50 above 100 mg.L-1 would not be classi‐
fied. Results obtained in test of acute toxicity on D. magna and T. platyurus are summarized
in Table 8. To compare toxicity of linear musk compounds with other musks in Table 9 are
summarized results obtained in our laboratory on the same testing organisms via the same
testing procedure [38].
Tested compounds
Thamnocephalus platyurus Daphnia magna
24hLC50 [mg.L-1] 24EC50 [mg.L-1] 48EC50[mg.L-1]
Lilial 11.98 4.4 2.13
Arocet 54.52 63.68 40.23
Arofloron 68.34 53.63 40.42
Linalool 53.94 156.26 124.59
Table 8. Results of acute toxicity tests of linear musks on Thamnocephalus platyurus and Daphnia magna.
Group Compound
Thamnocephalus
platyurus
Daphnia magna
24h LC50
[mg.L-1]
24h EC50
[mg.L-1]
48h EC50
[mg.L-1]
Nitromusks
Musk xylene 6.15 2.39 2.22
Musk ketone 6.14 2.33 2.13
Polycyclic musks
Galaxolide (HHCB) 1.14 1.22 1.12
Tonalide (AHTN) 1.58 1.51 1.33
Table 9. Results of acute toxicity tests of nitromusks and polycyclic musks on Thamnocephalus platyurus and Daphnia
magna.
From compounds tested in our study lilial was found as the most toxic to testing organisms.
Although we have ecotoxicological values only on one organism defined for chemicals wa‐
ter ecotoxicity assessment, on the base of 48EC50 values obtained for D. magna we could try
to classify them as follows: all substances except linalool and lilial were harmful to aquatic
organisms (class-III). Lilial was found to be toxic to aquatic organisms (class-II). From re‐
sults obtained on a limited number of species it seems that linalool is not hazardous to
aquatic environment. In comparison with results obtained in our similar study on the same
testing organism for polycyclic and nitro musk (see Table 9) we can conclude that linear
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musk compounds are more friendly to the environment than polycyclic and nitro musks.
The 48EC50 values for tonalide, galaxolide, musk ketone and musk xylene on D. magna were
1.33 mg.L-1, 1.12 mg.L-1, 2.13 mg.L-1 and 2.22 mg.L-1, respectively. In this case they could be
classified as toxic to aquatic organisms (II-class). As seems the linear musk compounds (ex‐
ception lilial) are in our case in the order of ten times less toxic to the testing organism T.
platyurus and D. magna than polycyclic and nitro musks. As mentioned above this finding is
very positive in view of prevention of environmental pollution because the production of
linear musk compounds in the Czech Republic is on the rise and replaces the use polycyclic
and nitro musk compounds. Equally important is the finding that the concentration at the
outlet of the WWTP was mostly below the detection limit as in this article published. Excep‐
tion is only lilial, but its levels detected at the WWTP outflow (mean value 0.047 μg.L-1, see
Table 7), are much lower than in our case the value of 24LC50 found in our experiments.
4. Conclusions
As a consequence of increasing living standard of mankind the environment is loaded with
increasing number of various chemicals. Pharmaceuticals and personal care products
(PPCPs) belong to the group with increasing use, but these compounds also attract increas‐
ing interest as new or emerging environmental contaminants. Negative effects of these com‐
pounds or formulations are caused not only by parent compounds, but also their
degradation or transformation products could show in some cases even stronger negative
effects than their precursors.
This study was focused on three groups of chemicals belonging to PPCPs: non-steroid anti-
inflammatory drugs, which are used widely, macrolide antibiotics which gain wider impor‐
tance due to their therapeutical properties, and linear musk compounds which represent the
most modern synthetic fragrances with great perspectives. The levels of these compounds at
the inflow and outflow of waste water in municipal waste water treatment plant in Brno-
Modřice were determined. From the group of non-steroid anti-inflammatory drugs ibupro‐
fen was the compound with the highest concentration in the raw waste water reaching more
than 40 μg.L-1, followed by salicylic acid and ketoprofen. The removal efficiency of the
cleaning process was found to be very good for all compounds under study with the excep‐
tion of naproxen – its removal efficiency was 78 %, in all other cases it was better than 90 %.
The levels of macrolide antibiotics (erythromycin, clarithromycin and roxithromycin) were
found to be very low in raw waste water (in several samples erythromycin and roxithromy‐
cin were found in sub- μg.L-1, their levels in cleaned waste water were below the limits of
detection of used analytical procedure. It could be stated that these compounds due to low
concentrations don’t represent any serious risk for the receiving water.
The concentrations of linear musks produced in the Czech Republic in the raw waste water
ranged from tens of μg.L-1 for linalool, units of μg.L-1 for arocet and aroflorone to sub- μg.L-1
levels for lilial and isoamylacetate. Removal efficiencies were in common better than 99.5 %
with exception of lilial with average removal efficiency of 88.7 %. The last compound also
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exhibited the highest ecotoxicity from all tested linear musk compounds with 24EC50 value
4.4 mg.L-1. Nevertheless, this value significantly exceeds the concentrations found in real
samples.
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